Shaoying Huang1, Fengping Zheng1, Lixiong Liu2, Shuhui Meng1, Wanxia Cai1, Cantong Zhang1, Weier Dai3, Dongzhou Liu2, Xiaoping Hong2, Donge Tang1, Yong Dai1,4. 1. Department of Clinical Medical Research Center, Guangdong Provincial Engineering Research Center of Autoimmune Disease Precision Medicine, Shenzhen People’s Hospital, The First Affiliated Hospital Southern University of Science and Technology, The Second Clinical Medical College of Jinan University, Shenzhen 518020, Guangdong, China. 2. Department of Rheumatology and Immunology, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen People’s Hospital, Shenzhen 518020, Guangdong, China. 3. College of Natural Science, University of Texas at Austin, Austin, TX 78712, USA. 4. Guangxi Key Laboratory of Metabolic Disease Research, Nephrology Department of Guilin, Guilin 541002, China.
Abstract
Primary Sjögren syndrome (pSS) is a common autoimmune disease. Here, we performed the first proteome and phosphoproteome analyses of peripheral blood mononuclear cells in pSS patients to obtain a comprehensive profile and identify the potential crucial proteins and pathways for the screening and evaluation of pSS patients. Peripheral blood mononuclear cells from 8 pSS-confirmed patients (American-European Consensus Group Criteria, 2002) and 10 normal controls were selected. Label-free quantitative proteomics was utilized to obtain quantitative information. In total, 787 proteins were identified as differentially expressed proteins, and 175 phosphosites on 123 proteins were identified as differentially phosphorylated proteins. We performed functional enrichment analyses with these proteins and phosphoproteins based on public database. Furthermore, protein-protein interaction network analyses were performed by using multiple algorithms. Using module and hub protein analyses, we identified 16 modules for the proteins, 2 clusters for the phosphoproteins and selected the top 10 hub proteins. Finally, we identified 22 motifs using motif analysis of the phosphosites and found 17 newly identified motifs, while 6 motifs were experimentally verified for known protein kinases. The findings distinguished pSS patients from normal controls at the peripheral blood mononuclear cells level and revealed potential candidates for use in pSS diagnosis.
Primary Sjögren syndrome (pSS) is a common pan class="Disease">autoimmune disease. Here, we performed the first proteome and phosphoproteome analyses of peripheral blood mononuclear cells in pSS patients to obtain a comprehensive profile and identify the potential crucial proteins and pathways for the screening and evaluation of pSS patients. Peripheral blood mononuclear cells from 8 pSS-confirmed patients (American-European Consensus Group Criteria, 2002) and 10 normal controls were selected. Label-free quantitative proteomics was utilized to obtain quantitative information. In total, 787 proteins were identified as differentially expressed proteins, and 175 phosphosites on 123 proteins were identified as differentially phosphorylated proteins. We performed functional enrichment analyses with these proteins and phosphoproteins based on public database. Furthermore, protein-protein interaction network analyses were performed by using multiple algorithms. Using module and hub protein analyses, we identified 16 modules for the proteins, 2 clusters for the phosphoproteins and selected the top 10 hub proteins. Finally, we identified 22 motifs using motif analysis of the phosphosites and found 17 newly identified motifs, while 6 motifs were experimentally verified for known protein kinases. The findings distinguished pSS patients from normal controls at the peripheral blood mononuclear cells level and revealed potential candidates for use in pSS diagnosis.
Authors: Kirti Sharma; Rochelle C J D'Souza; Stefka Tyanova; Christoph Schaab; Jacek R Wiśniewski; Jürgen Cox; Matthias Mann Journal: Cell Rep Date: 2014-08-21 Impact factor: 9.423
Authors: L G Gøransson; K Haldorsen; J G Brun; E Harboe; M V Jonsson; K Skarstein; K Time; R Omdal Journal: Scand J Rheumatol Date: 2011-01-13 Impact factor: 3.641
Authors: Carlson Tsui; Nuria Martinez-Martin; Mauro Gaya; Paula Maldonado; Miriam Llorian; Nathalie M Legrave; Merja Rossi; James I MacRae; Angus J Cameron; Peter J Parker; Michael Leitges; Andreas Bruckbauer; Facundo D Batista Journal: Immunity Date: 2018-06-05 Impact factor: 31.745
Authors: Cameron R Stewart; Lynda M Stuart; Kim Wilkinson; Janine M van Gils; Jiusheng Deng; Annett Halle; Katey J Rayner; Laurent Boyer; Ruiqin Zhong; William A Frazier; Adam Lacy-Hulbert; Joseph El Khoury; Douglas T Golenbock; Kathryn J Moore Journal: Nat Immunol Date: 2009-12-27 Impact factor: 25.606
Authors: Olga V Moroz; Will Burkitt; Helmut Wittkowski; Wei He; Anatoli Ianoul; Vera Novitskaya; Jingjing Xie; Oxana Polyakova; Igor K Lednev; Alexander Shekhtman; Peter J Derrick; Per Bjoerk; Dirk Foell; Igor B Bronstein Journal: BMC Biochem Date: 2009-04-23 Impact factor: 4.059